RxDoctor Payments Data

Tami Hite, NP

Nurse Practitioner · Mansfield, PANPI 1811430994

Payments from drug & device makers

$2,387in general payments, 2019–2025

Across 135 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$178
  • Lilly USA, LLC$161
  • Organon$121
  • GSK$115
  • AstraZeneca$112
  • plus $662 from 16 others

What the payments were for

  • Food & beverage$2,387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,387 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$69,507
Medicare patients
257
Services billed
1,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$55,168
EliquisApixaban54$51,506
JardianceEmpagliflozin26$28,428
Trelegy ElliptaFluticasone/Umeclidin/Vilanter24$18,029
Cinacalcet Hcl12$12,213
RybelsusSemaglutide12$11,052
EntrestoSacubitril/Valsartan15$9,922
Sucralfate35$6,546
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$4,893
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,950
Levothyroxine Sodium353$3,741
Pantoprazole Sodium118$3,204
Vilazodone Hcl26$3,151
Humalog Kwikpen U-100Insulin Lispro16$2,761
Omeprazole255$2,709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,037$66,22066 claims
Boehringer IngelheimJardiance$21$28,42826 claims
GSKTrelegy Ellipta$115$18,02924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Mansfield

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →